vaccines
EU and drug industry set aside €280m for Ebola
November 7, 2014Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west
The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …
GSK: Ebola vaccines will come ‘too late’
October 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp
GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …
Novartis says three executives departing firm
October 9, 2014Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines
Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …
FDA warns GSK plant
June 26, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, Quebec, flu, flulaval, vaccines
GlaxoSmithKline’s Canadian operation has incurred the displeasure of the US Food and Drug Administration for irregularities in its production of …
Novartis back under microscope
June 23, 2014Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines
Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …
GSK and Novartis sign multi-billion dollar deal
April 23, 2014Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines
GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …
GSK halts chickenpox vaccines over quality concerns
January 29, 2014Manufacturing and Production, Sales and Marketing Boostrix-Polio, GSK, Varilrix, chickenpox, vaccines
GlaxoSmithKline has suspended worldwide distribution of two chickenpox vaccines after production standards were not met at one of its facilities …
Sanofi cuts earnings guidance despite return to sales growth
October 31, 2013Sales and Marketing Sanofi, Viehbacher, vaccines
Sanofi cut its earnings guidance for 2013 after its third quarter results missed targets, despite a return – barely – …
GSK strikes new vaccines deal with Gates Foundation
October 30, 2013Research and Development, Sales and Marketing GSK, Gates, bmgf, vaccines
GSK and the Bill & Melinda Gates Foundation (BMGF) will invest a combined $1.8 million in early-stage research into making …
ABPI takes on vaccine industry brief
May 22, 2013Research and Development ABPI, vaccines
The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …
Sanofi Pasteur MSD appoint president of Vaccines Europe
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrea Rappagliosi, Sanofi pasteur msd, vaccines
Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president …
Novartis says Canada and Switzerland lift vaccines ban
November 2, 2012Manufacturing and Production Canada, Novartis, Switzerland, vaccines
A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …
Canada latest country to suspend sales of Novartis vaccines
October 30, 2012Manufacturing and Production Canada, Novartis, vaccines
Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …
EU countries suspend sales of Novartis flu vaccines
October 29, 2012Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines
Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …
Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud
March 29, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines
Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors. Mahmoud, a global infectious …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
